IASO VENTURES MANAGEMENT FIRM LLC

Thesis

Iaso Ventures is a Boston-based venture capital firm founded in 2018, dedicated to fostering innovation within the biodigital healthcare space. The firm primarily focuses on early-stage investments, specifically in Seed and Series A rounds, targeting companies that are developing data-driven enabling technologies and platforms crucial for next-generation therapeutic development. Their geographic scope is predominantly the United States. The investment thesis centers on the healthcare sector, with a strong emphasis on brain health, behavioral health, mental health, neurodegenerative diseases, and cognitive enhancement. They actively seek startups that are creating non-pharmacological interventions, AI-enabled drug discovery solutions, advanced drug design and delivery platforms, and innovative digital health tools. Additionally, Iaso Ventures invests in companies within the AI and biotechnology sectors. While specific current AUM figures are not publicly disclosed, the firm was seeking to raise $50 million for a new fund in November 2020 and has a history of investments, particularly in Series A rounds. Specific check sizes are not publicly disclosed, but investments typically fall within the range of hundreds of thousands to several million dollars for Seed and Series A rounds.

Related lists

• Seed-stage AI investors
• Seed-stage Healthcare investors
• Series A AI investors